Delisting risk
Bluejay Diagnostics (BJDX)
Develops near-patient IL-6 diagnostics for sepsis risk assessment.
$0.8500
Pre-market+0.00 (+0.57%)
At close$0.8452(−0.27%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions6 holders · as of Mar 31, 2026 | 5.69% | 58.8K shares | |
| Insiders5 holders · as of Aug 18, 2026 | 8.76% | 90.7K shares | |
| Strategic holders2 holders · as of Jul 22, 2026 | 8.90% | 92.1K shares | |
| Otherremainder | 76.65% | 793.2K shares |
1.03M company shares as of Aug 25, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (4.47M in the company's Sep 3, 2026 report, 1.03M elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
6 holders · 58.8K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sabby Management, LLC | 28.7K | 2.78% | May 15, 2026 | |
| Geode Capital Management, LLC | 28.1K | 2.72% | May 15, 2026 | |
| Tower Research Capital LLC (TRC) | 1.7K | 0.17% | May 15, 2026 | |
| UBS Group AG | 124 | 0.01% | May 5, 2026 | |
| L1 Global Manager PTY Ltd | 120 | 0.01% | May 15, 2026 | |
| Caitong International Asset Management Co., Ltd | 3 | 0.00% | May 11, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 142.7K | 13G | Aug 14, 2026 ↗ |
| Ayrton Capital LLC | 9.99% | 107.7K | 13G | Aug 13, 2026 ↗ |
| Mitchell P. Kopin | 9.99% | 0 | 13G | Jun 5, 2026 ↗ |
| Moez Kassamincl. Tony Moore, Anson Advisors Inc. +3 more | 5.10% | 13G | Nov 14, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 10, 2026 | HRT Financial LP10 percent owner | Sale | 34,938 | $1.40 | 92,055 |
| Jul 9, 2026 | HRT Financial LP10 percent owner | Purchase | 64,047 | $1.51 | 126,993 |
| Mar 14, 2026 | Svetlana Deydirector | Purchase | 12,500 | $2.00 | 12,501 |
| Mar 14, 2026 | Fred S. Zeidmandirector | Purchase | 12,500 | $2.00 | 12,500 |
| Mar 14, 2026 | Donald R. Chasedirector | Purchase | 12,500 | $2.00 | 12,525 |
| Mar 14, 2026 | Indranil Deydirector, officer: President and CEO | Purchase | 12,500 | $2.00 | 12,522 |
| Mar 14, 2026 | Douglas Clark Wurthdirector | Purchase | 12,500 | $2.00 | 12,608 |
CongressHouse and Senate disclosures
Not reported.
